Get started
Author

Alice Durand

ORCID: 0000-0002-0193-9058
Observed ORCIDs: 0000-0002-0193-9058, 0009-0008-4541-7500
OpenAlex ID: A5058948162
PFMG2025–integrating genomic medicine into the national healthcare system in France
2025 · Caroline Abadie, Aldja Abderrahmane, et al. · The Lancet Regional Health - Europe · 57
PDF
Belzutifan for Advanced Pheochromocytoma or Paraganglioma
2025 · Camilo Jimenez, Mikkel Andreassen, et al. · New England Journal of Medicine · 46
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
2021 · Oliver Illini, Maximilian Johannes Hochmair, et al. · Therapeutic Advances in Medical Oncology · 44
PDF
ctDNA in Neuroendocrine Carcinoma of Gastroenteropancreatic Origin or of Unknown Primary: The CIRCAN-NEC Pilot Study
2020 · Laura Gerard, Jessica Garcia, et al. · Neuroendocrinology · 32
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O 6 -Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
2024 · Thomas Walter, Thierry Lecomte, et al. · Journal of Clinical Oncology · 22
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
2025 · Jaume Capdevila, Virginia Pubul, et al. · BMC Cancer · 14
PDF
European Society of Neuroendocrine Tumors ( ENETS ) 2025 guidance paper for lung and thymic carcinoids
2026 · Eric Baudin, Alice Durand, et al. · Journal of Neuroendocrinology · 13
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network
2024 · Aurelien Fosse, Julien Hadoux, et al. · Journal of Nuclear Medicine · 13
PDF
Olaparib as maintenance therapy in non resectable pancreatic adenocarcinoma associated with homologous recombination deficiency profile: A French retrospective multicentric AGEO real-world study
2024 · Jeannie M’Baloula, David Tougeron, et al. · European Journal of Cancer · 11
PDF
Post first-line dacarbazine or temozolomide in neuroendocrine carcinoma
2020 · Thomas Couronne, Paul Girot, et al. · Endocrine Connections · 8
PDF
Characterization, Prognosis, and Treatment of Patients With Locally Advanced or Metastatic Thymic Neuroendocrine Tumor: A Retrospective Study of the French GTE, ENDOCAN RENATEN, and RYTHMIC Networks
2025 · Sarah Fodil-Cherif, Julien Hadoux, et al. · Journal of Thoracic Oncology · 6
PDF
Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management
2026 · Anna Koumarianou, Jules Derks, et al. · Endocrine Reviews · 5
Emergence of DNA Damage Repair Clonal Hematopoiesis after Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
2024 · Romain Loyaux, Julien Hadoux, et al. · Blood · 5
Tumor-intrinsic chemosensitivity assessed by KELIM and prognosis by BRCA status in patients with advanced ovarian carcinomas
2024 · Ondine Becker, Alice Durand, et al. · International Journal of Gynecological Cancer · 5
PDF
A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022–2023
2024 · Nagham Khanafer, Sylvain Oudot, et al. · Vaccine · 5
[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
2026 · Eric Baudin, Alice Durand, et al. · The Lancet Oncology · 4
Serum and urinary 5-hydroxyindolacetic acid, serotonin, chromogranin A, and NT-proBNP for the detection of carcinoid heart disease
2024 · Antoine Lecoeur, Rita-Maria Sfeir, et al. · European Journal of Endocrinology · 3
Diagnostic value of the wnt target and cancer-associated blood biomarker hPG80: ONCOPRO case-control prospective study
2025 · Benoit You, Sebastien Couraud, et al. · Biomarker Research · 2
PDF
Neuropilin 2 and soluble neuropilin 2 in neuroendocrine neoplasms
2024 · Laura Gerard, Céline Patte, et al. · Endocrine Related Cancer · 2
Large Language Models for Patient Education: Insights from Cross-Lingual Expert Evaluation in Radioligand Therapy for Neuroendocrine Tumors
2026 · Vincent Habouzit, Alice Durand, et al. · Journal of Cancer Education · 1
Clinical and Pathological Features of EC-cell Familial Small Intestine Neuroendocrine Tumors: A Nationwide Cohort From the French GTE-RENATEN Network
2026 · Thomas Hunaut, Laura Gérard, et al. · Endocrine Pathology · 1
Fluorinated radiopharmaceuticals sorption onto plasticized polyvinyl chloride automated injector tubings: implications for patient dosing
2026 · Lola Kazek, Perrine Tylski, et al. · International Journal of Pharmaceutics
Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort)
2026 · Claire Noé, Julie Henriques, et al. · JHEP Reports
PDF
Correction: A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
2026 · Jaume Capdevila, Virginia Pubul, et al. · BMC Cancer
PDF
Bifocal Insulinoma Detected With 68Ga-Exendin PET/CT and Treated With Endoscopic Ultrasound-guided Radiofrequency Ablation: Toward a Gold-Standard Management?
2025 · Aurélie Moreau, Romain Lhuillier, et al. · Clinical Nuclear Medicine
Works count: 29
Citation count: 292
H-index: 9
I10-index: 9
Year
Topic
Type